Skip to main content

Table 2 Estimates of general population anti-HCV-Ab prevalence, and number of anti-HCV positive people in the general population, by country, Europe, 2000-2009

From: Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening

Country* (Reference)

Period

Area

Region

Sampling

N

%

95% CI**

Remarks

Population size [36]

Number of inhabitants who are anti-HCV-Ab positive

Belgium [91]

2003

regional

Flanders

random

1.834

0,1

(0.1-0.4) &

Oral fluid

10.754.528

64.527

Belgium [111]

1993-1994

regional

Flanders

random

4.055

0,9

(0.5-1.1) &

   

Bulgaria [112]

1999-2000

regional

South-Central

convenience

2.211

1,3

(1.2-1.4) &

Standardized

7.606.551

98.885

Czech Republic [92]

2001

nationwide

-

random

2.658

0,2

(0.1-0.4)$

 

10.467.542

20.935

France [113]

1997

regional

South

convenience

11.804

1,3

(1.1-1.5) &

 

64.351.000

836563

Germany [95]

1998

nationwide

-

random

6.748

0,4

(0.2-0.5) &

 

82.050.000

328200

Greece [96]

1997-1998

regional

Peloponnesos

random

1.500

0,5

(0.2-1.1) &

 

11.257.285

112.573

Greece [114]

1997

regional

Zakinthos

random

718

1,3

(0.6-2.4) $

   

Italy [74]

2002

regional

North

convenience

956

2,6

(1.7-3.8) $

   

Italy [115]

1994-1995

regional

North

convenience

2.154

3,3

(2.6-4.1) &

   

Italy [116]

Not reported

regional

North

convenience

4.820

2,4

(2.0-2.8) &

   

Italy [117]

Not reported

regional

Central

convenience

300

16,3

(12.0-20.6) &

   

Italy [97]

1997

regional

Central

random

250

22,4

(20.8-24.1) &

   

Italy [98]

Not reported

regional

South

random

488

16,2

(13.0-19.8) $

   

Italy [118]

2000-2002

regional

South

convenience

2.753

7,9

(6.9-9.0) $

   

Italy [99]

2002-2003

regional

South

random

1.645

6,5

(5.3-7.7) &

   

Italy [100]

1994-1995

regional

Sardinia

convenience

3.324

3,2

(2,6-3,8) $

   

Italy [101]

1999-2000

regional

Sicily

random

721

10,4

(8,2-12,9) $

   

Netherlands [41]

2004

regional

Amsterdam

random

1.364

0,6

(0.1-1.1) &

Standardized

16.486.587

65.946

Netherlands [119]

2006

regional

East

convenience

2.200

0,2

(0.1-0.5) $

   

Poland [120]

1999

regional

North

convenience

2.561

1,9

(1.4-2.5) $

 

38.135.876

724.582

Romania [121]

2006-2008

nationwide

-

random

8.039

3,5

(3.1-3.9) &

 

21.498.616

752.452

Spain [122]

1996

regional

Catalonia

random

2.142

2,5

(1.8-3.2) &

Standardized

45.828.172

916.563

Spain [123]

1997-1998

regional

North

random

1.170

1,6

(1.0-2.6) &

   

Sweden [104]

1991-1994

regional

Malmö

random

5.533

0,4

(0,3-0,6) $

 

9.256.347

37.025

Turkey [105]

2006-2007

regional

South West

random

2.852

1,0

(0,7-1,4) $

 

71.517.100

1.072.757

Turkey [106]

2002-2004

regional

Central

convenience

1.320

2,2

(1,5-3,1) $

   

Turkey [108]

Not reported

regional

Central

random

1.095

2,1

(1,3-3,1) $

   

United Kingdom [124]

1996

regional

England&Wales

residual

6.401

0,7

(0,1-0,5) $

 

61634599

431442

  1. * No estimate of anti-HCV general population prevalence was found for Austria, Croatia, Cyprus, Denmark, Estonia, Finland, Former Yugoslav Republic of Macedonia, Hungary, Iceland, Ireland, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Slovakia, Slovenia and Switzerland.
  2. ** CI Confidence interval.
  3. & CI provided in the original paper.
  4. $ CI estimated by the exact method.